1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Research Loan (SRL) program (North Carolina) is sponsored by North Carolina Biotechnology Center (NC Biotech Center). This program invests in promising, emerging life sciences companies across the state of North Carolina. The SRL program specifically supports business inception and research critical to developing products, processes, or tools with clear commercial potential.
Get alerted about grants like this
Get emailed when new opportunities from “North Carolina Biotechnology Center (NC Biotech Center)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Emerging life sciences companies based in North Carolina. Confirm the full requirements in the official notice before applying.
The current listing shows $150,000 to $350,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Small Business Research Loan (SRL) program (North Carolina) is funded by North Carolina Biotechnology Center (NC Biotech Center). Verify program details on the funder's official page before applying.
This opportunity targets applicants in North Carolina. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On July 22, 2026, the Department of Energy opened the first Phase I SBIR/STTR release tied to its Genesis Mission — roughly 40 awards across biotechnology, AI-for-quantum, predictable-materials design, and autonomous laboratories — alongside about $147M in FY25 Phase II funding. Here is what each topic area actually wants, who is eligible, how this connects to the $5B Genesis Mission, and how a small business should position before the broader fall solicitation.
Read articleThe NSF FY 2026-2030 Strategic Plan reorganizes the agency around three goals, names AI, quantum, and biotech as the critical technologies, codifies Gold Standard Science, and explicitly targets applicant burden. The implications for proposal strategy are bigger than they look.
Read articleDARPA pre-released four FY26 SBIR topics on April 30 — SWiFT field transfusion, BARK K-9 therapeutics, EXPOSITION finger regeneration, and PEPI photonic-electronic integration. Phase I awards range $150K-$300K, with Direct-to-Phase-II up to $1.8M. Closing June 3.
Read article